Cerebrolysin
Cerebrolysin is a porcine-brain peptide mixture sold as a master key for brain repair. It has decades of human trials, approval in 50+ countries, no FDA approval, and a Cochrane safety signal that complicates the story.
Cerebrolysin is a porcine-derived neurotrophic peptide preparation studied for stroke, TBI, and dementia. Human RCT data exists but is heterogeneous and industry-weighted, independent Cochrane reviews find no mortality benefit and a serious-adverse-event signal, and it is not FDA-approved.
CerebrolysinpeptidesneurotrophicstrokeTBI+2